BIOMENDEX
Biomendex develops and manufactures adaptable synthetic bone substitute materials for bone regeneration. Their invention, Adaptos®, is the first bioactive bone graft substitute that surgeons can cut, shape or squeeze into place. It is the only bone graft substitute that mimics bone by being resilient and bioactive. Adaptos® bone graft substitutes are being developed for clinical and veterinary use.
BIOMENDEX
Industry:
Biotechnology Health Care Manufacturing
Founded:
2018-01-01
Address:
Tampere, Western Finland, Finland
Country:
Finland
Website Url:
http://www.biomendex.com
Total Employee:
1+
Status:
Active
Total Funding:
2.25 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Aerogen
Aerogen is a medical device and drug delivery company.
Cerus
Cerus is a biomedical products company focused in the field of blood safety.
CoreBone
CoreBone is a bioactive coral-based bone graft substitute material.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Employees Featured
Founder
Investors List
European Innovation Council
European Innovation Council investment in Grant - Biomendex
Official Site Inspections
http://www.biomendex.com
- Host name: 255.56.88.34.bc.googleusercontent.com
- IP address: 34.88.56.255
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Biomendex"
Biomendex – Who we are and what we stand for.
Biomendex also works to enhance tissue technology and manufactures superior medical devices. We aim to resolve various problems in the fields of oral and maxillofacial surgery, orthopedic …See details»
Biomendex - Crunchbase Company Profile & Funding
Biomendex develops and manufactures adaptable synthetic bone substitute materials for bone regeneration. Their invention, Adaptos®, is the first bioactive bone graft substitute that …See details»
Biomendex Company Profile 2024: Valuation, Funding …
Biomendex General Information Description. Developer of adaptable synthetic bone substitute materials designed to be used for bone regeneration. The …See details»
Biomendex Management Team | Org Chart - RocketReach
The Biomendex management team includes Pasi Kankaanpää (Chief Executive Officer), Kaarlo Paakinaho (Founder), and Veli-Matti Lahti (Chairman of the Board, Partner). Get Contact Info …See details»
Biomendex - LinkedIn
Biomendex will be attending the ESVOT 2024 European Society of Veterinary Orthopaedics and Traumatology conference in Lisbon, taking place from September 25-28, 2024, at the Lisbon …See details»
Biomendex - Overview, News & Similar companies | ZoomInfo.com
Who is Biomendex. We at Biomendex develop and manufacture adaptable synthetic bone substitute materials for bone regeneration. Our invention, Adaptos™, is the first bioactive bone …See details»
Biomendex Company Profile - Office Locations, Competitors
Biomendex has 5 employees at their 1 location. See insights on Biomendex including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Biomendex - Funding, Financials, Valuation & Investors - Crunchbase
Organization. Biomendex . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... obfuscated. in funding over 1 round. This was a Grant …See details»
Biomendex - Crunchbase
The first adaptive bone graft substitute in the world.See details»
Biomendex
Biomendex — Supplier,Other from Finland with 11-50 employees, has experience with Horizon 2020 (2014 - 2020), it`s involved in Health, Mechanical Engineering, Science & Innovation …See details»
Biomendex is throwing more than a bone to orthopaedists - Good …
Tampere-based Biomendex has developed a more convenient and less risky alternative to bone grafts. A rather unusual pet project has evolved into a full-time undertaking for Kaarlo …See details»
The new page for Biomendex has been opened! - LinkedIn
Apr 12, 2024 #Biomendex, #Adaptos, #orthopedics, #bonegraft, #clinicaltrial Help improve contributions Mark contributions as unhelpful if you find them irrelevant or not valuable to the …See details»
Biomendex – Superior adaptable bone grafts
Biomendex follows ISO14155:2020 when carrying out clinical studies. Data provided by clinical investigations plays an essential role in clinical evaluation to demonstrate safety and efficacy …See details»
Biomendex Enters Collaboration with Mayo Clinic
Oct 30, 2024 Biomendex is continuing the development of its fully synthetic and biodegradable bone graft material, Adaptos, to enable better outcomes for patients and surgeons. Currently, …See details»
Biomendex announces collaboration with Mayo Clinic
Posted on 29.10.2024 by Biomendex. Share: We’re excited to announce our collaboration with Mayo Clinic to further develop our fully synthetic and biodegradable bone graft material, …See details»
Biomendex enters into collaboration with Mayo Clinic
Currently, Biomendex is undergoing the FDA approval process for Adaptos® within the spinal surgery segment in the United States. Through a recently executed know-how agreement, …See details»
Biomendex – Groundbreaking technology behind Adaptos®
The use of Adaptos ® bone graft substitute reduces the need for autologous bone grafting, which leads to decreased surgery time as well as fewer complications. It also improves current …See details»
Biomendex – News
Mar 7, 2023 See the latest updates from Biomendex. 29.10.2024 Biomendex announces collaboration with Mayo Clinic. 28.05.2024 Adaptos®Vet ist jetzt auch in Deutschland …See details»
Biomendex – Clinical studies and their importance
The primary objective of the study is to evaluate the efficacy and safety of Adaptos®Ortho Wedge in HTO application by comparing the bone regeneration of the osteotomy defect between three …See details»